Works matching IS 02704137 AND DT 2021 AND VI 81 AND IP 16


Results: 22
    1

    Cover Image: Volume 81 Issue 16.

    Published in:
    Prostate, 2021, v. 81, n. 16, p. i, doi. 10.1002/pros.24265
    By:
    • Liu, Daoquan;
    • Liu, Jianmin;
    • Li, Yan;
    • Liu, Huan;
    • Hassan, Hassan M.;
    • He, Weixiang;
    • Li, Mingzhou;
    • Zhou, Yongying;
    • Fu, Xun;
    • Zhan, Junfeng;
    • Wang, Zhen;
    • Yang, Shu;
    • Chen, Ping;
    • Xu, Deqiang;
    • Wang, Xinhuan;
    • DiSanto, Michael E.;
    • Zeng, Guang;
    • Zhang, Xinhua
    Publication type:
    Article
    2
    3

    Upregulated bone morphogenetic protein 5 enhances proliferation and epithelial–mesenchymal transition process in benign prostatic hyperplasia via BMP/Smad signaling pathway.

    Published in:
    Prostate, 2021, v. 81, n. 16, p. 1435, doi. 10.1002/pros.24241
    By:
    • Liu, Daoquan;
    • Liu, Jianmin;
    • Li, Yan;
    • Liu, Huan;
    • Hassan, Hassan M.;
    • He, Weixiang;
    • Li, Mingzhou;
    • Zhou, Yongying;
    • Fu, Xun;
    • Zhan, Junfeng;
    • Wang, Zhen;
    • Yang, Shu;
    • Chen, Ping;
    • Xu, Deqiang;
    • Wang, Xinhuan;
    • DiSanto, Michael E.;
    • Zeng, Guang;
    • Zhang, Xinhua
    Publication type:
    Article
    4
    5

    Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level.

    Published in:
    Prostate, 2021, v. 81, n. 16, p. 1411, doi. 10.1002/pros.24239
    By:
    • Yoneyama, Tohru;
    • Yamamoto, Hayato;
    • Sutoh Yoneyama, Mihoko;
    • Tobisawa, Yuki;
    • Hatakeyama, Shingo;
    • Narita, Takuma;
    • Kodama, Hirotake;
    • Momota, Masaki;
    • Ito, Hiroyuki;
    • Narita, Shintaro;
    • Tsushima, Fumiyasu;
    • Mitsuzuka, Koji;
    • Yoneyama, Takahiro;
    • Hashimoto, Yasuhiro;
    • Duivenvoorden, Wilhelmina;
    • Pinthus, Jehonathan H.;
    • Kakeda, Shingo;
    • Ito, Akihiro;
    • Tsuchiya, Norihiko;
    • Habuchi, Tomonori
    Publication type:
    Article
    6
    7
    8

    Efficacy of systemic therapies in men with metastatic castration resistant prostate cancer harboring germline ATM versus BRCA2 mutations.

    Published in:
    Prostate, 2021, v. 81, n. 16, p. 1382, doi. 10.1002/pros.24236
    By:
    • Sokolova, Alexandra O.;
    • Marshall, Catherine H.;
    • Lozano, Rebeca;
    • Gulati, Roman;
    • Ledet, Elisa M.;
    • De Sarkar, Navonil;
    • Grivas, Petros;
    • Higano, Celestia S.;
    • Montgomery, Bruce;
    • Nelson, Peter S.;
    • Olmos, David;
    • Sokolov, Vadim;
    • Schweizer, Michael T.;
    • Yezefski, Todd A.;
    • Yu, Evan Y.;
    • Paller, Channing J.;
    • Sartor, Oliver;
    • Castro, Elena;
    • Antonarakis, Emmanuel S.;
    • Cheng, Heather H.
    Publication type:
    Article
    9

    Improvement in overall and cancer‐specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients.

    Published in:
    Prostate, 2021, v. 81, n. 16, p. 1374, doi. 10.1002/pros.24235
    By:
    • Hoeh, Benedikt;
    • Würnschimmel, Christoph;
    • Flammia, Rocco S.;
    • Horlemann, Benedikt;
    • Sorce, Gabriele;
    • Chierigo, Francesco;
    • Tian, Zhe;
    • Saad, Fred;
    • Graefen, Markus;
    • Gallucci, Michele;
    • Briganti, Alberto;
    • Terrone, Carlo;
    • Shariat, Shahrokh F.;
    • Tilki, Derya;
    • Kluth, Luis A.;
    • Mandel, Philipp;
    • Chun, Felix K. H.;
    • Karakiewicz, Pierre I.
    Publication type:
    Article
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22

    Issue Information.

    Published in:
    Prostate, 2021, v. 81, n. 16, p. 1265, doi. 10.1002/pros.24014
    Publication type:
    Article